Analytical Data
-
基因名
CDC45L
- Application
-
别名
CDC45. CDC45L. CDC45L2. UNQ374/PRO710
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O75419
-
表达区间
1-566aa
-
氨基酸序列
MFVSDFRKEFYEVVQSQRVLLFVASDVDALCACKILQALFQCDHVQYTLVPVSGWQELETAFLEHKEQFHYFILINCGANVDLLDILQPDEDTIFFVCDTHRPVNVVNVYNDTQIKLLIKQDDDLEVPAYEDIFRDEEEDEEHSGNDSDGSEPSEKRTRLEEEIVEQTMRRRQRREWEARRRDILFDYEQYEYHGTSSAMVMFELAWMLSKDLNDMLWWAIVGLTDQWVQDKITQMKYVTDVGVLQRHVSRHNHRNEDEENTLSVDCTRISFEYDLRLVLYQHWSLHDSLCNTSYTAARFKLWSVHGQKRLQEFLADMGLPLKQVKQKFQAMDISLKENLREMIEESANKFGMKDMRVQTFSIHFGFKHKFLASDVVFATMSLMESPEKDGSGTDHFIQALDSLSRSNLDKLYHGLELAKKQLRATQQTIASCLCTNLVISQGPFLYCSLMEGTPDVMLFSRPASLSLLSKHLLKSFVCSTKNRRCKLLPLVMAAPLSMEHGTVTVVGIPPETDSSDRKNFFGRAFEKAAESTSSRMLHNHFDLSVIELKAEDRSKFLDALISLLS
-
分子量
88 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDC45L (Cell Division Cycle 45-Like) is a critical protein involved in DNA replication and cell cycle regulation. It plays a crucial role in the formation and function of the pre-replication complex, which is essential for initiating DNA synthesis during the S phase of the cell cycle. Studies have shown that CDC45L interacts with key components of the DNA replication machinery, including MCM (Minichromosome Maintenance) proteins and other essential factors, ensuring proper DNA unwinding and replication fork progression. Dysregulation of CDC45L expression has been associated with various cancers, emphasizing its potential as a biomarker for tumorigenesis and a target for therapeutic interventions. Research into CDC45L recombinant proteins facilitates the study of its functional properties, protein interactions, and therapeutic implications in cancer biology. By characterizing CDC45L through recombinant expression systems, scientists aim to elucidate its role in cell cycle regulation, DNA repair mechanisms, and overall genomic stability, providing valuable insights into its contributions to cancer development and progression. Understanding the molecular mechanisms involving CDC45L could pave the way for innovative strategies in cancer treatment and personalized medicine.
